These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 26541225

  • 1. MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.
    Xu P, Li Y, Zhang H, Li M, Zhu H.
    J Oral Maxillofac Surg; 2016 Apr; 74(4):844-50. PubMed ID: 26541225
    [Abstract] [Full Text] [Related]

  • 2. miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
    Nie S, Li K, Huang Y, Hu Q, Gao X, Jie S.
    J Craniofac Surg; 2015 Mar; 26(2):e155-8. PubMed ID: 25759932
    [Abstract] [Full Text] [Related]

  • 3. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
    Chen X, Yu J, Tian H, Shan Z, Liu W, Pan Z, Ren J.
    J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X, Lu C, Chu W, Zhang B, Zhen Q, Wang R, Zhang Y, Li Z, Lv B, Li H, Liu J.
    Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
    Fan JY, Yang Y, Xie JY, Lu YL, Shi K, Huang YQ.
    Tumour Biol; 2016 May; 37(5):6855-60. PubMed ID: 26662316
    [Abstract] [Full Text] [Related]

  • 6. MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.
    Yan Y, Yan F, Huang Q.
    Arch Oral Biol; 2018 Dec; 96():52-57. PubMed ID: 30179745
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J, Chen Z, Wang Q.
    Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
    Xu XJ, Yuan J, Sun WJ, Chen QY, Lin Y, Tang L, Liang LZ.
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7726-7734. PubMed ID: 30536316
    [Abstract] [Full Text] [Related]

  • 9. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
    Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI.
    Clin Cancer Res; 2008 May 01; 14(9):2588-92. PubMed ID: 18451220
    [Abstract] [Full Text] [Related]

  • 10. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
    Lin J, Lin Y, Fan L, Kuang W, Zheng L, Wu J, Shang P, Wang Q, Tan J.
    Biochem Biophys Res Commun; 2016 Apr 29; 473(2):382-7. PubMed ID: 26946357
    [Abstract] [Full Text] [Related]

  • 11. miR-186 regulates glycolysis through Glut1 during the formation of cancer-associated fibroblasts.
    Sun P, Hu JW, Xiong WJ, Mi J.
    Asian Pac J Cancer Prev; 2014 Apr 29; 15(10):4245-50. PubMed ID: 24935378
    [Abstract] [Full Text] [Related]

  • 12. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
    Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT, Lin SC.
    Oral Oncol; 2013 Jan 29; 49(1):27-33. PubMed ID: 22854067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L, Ma HQ.
    Mol Med Rep; 2015 Aug 29; 12(2):3156-62. PubMed ID: 25955794
    [Abstract] [Full Text] [Related]

  • 17. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K.
    Carcinogenesis; 2013 Mar 29; 34(3):560-9. PubMed ID: 23233740
    [Abstract] [Full Text] [Related]

  • 18. miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.
    Libório-Kimura TN, Jung HM, Chan EK.
    Oral Oncol; 2015 Feb 29; 51(2):151-7. PubMed ID: 25500095
    [Abstract] [Full Text] [Related]

  • 19. Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells.
    Yuan G, Zhao Y, Wu D, Gao Ch.
    Asian Pac J Cancer Prev; 2017 Apr 01; 18(4):1127-1131. PubMed ID: 28547952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.